

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of necroptotic process (GO:0060546) | 9.65068046 |
| 2 | labyrinthine layer blood vessel development (GO:0060716) | 8.84655784 |
| 3 | regulation of macrophage activation (GO:0043030) | 8.79676356 |
| 4 | negative regulation of Notch signaling pathway (GO:0045746) | 8.49014562 |
| 5 | embryonic digestive tract morphogenesis (GO:0048557) | 8.39009360 |
| 6 | glandular epithelial cell differentiation (GO:0002067) | 8.21547208 |
| 7 | regulation of keratinocyte differentiation (GO:0045616) | 8.04816203 |
| 8 | negative regulation of necrotic cell death (GO:0060547) | 7.82501771 |
| 9 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 7.53416609 |
| 10 | negative regulation of epithelial to mesenchymal transition (GO:0010719) | 7.46108899 |
| 11 | regulation of necroptotic process (GO:0060544) | 7.38077017 |
| 12 | regulation of keratinocyte proliferation (GO:0010837) | 7.33385911 |
| 13 | trabecula formation (GO:0060343) | 7.20286368 |
| 14 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 6.77637563 |
| 15 | regulation of digestive system process (GO:0044058) | 6.59691434 |
| 16 | cellular response to arsenic-containing substance (GO:0071243) | 6.05100814 |
| 17 | morphogenesis of embryonic epithelium (GO:0016331) | 5.91495206 |
| 18 | regulation of cell maturation (GO:1903429) | 5.71453822 |
| 19 | placenta blood vessel development (GO:0060674) | 5.59869593 |
| 20 | cellular response to cadmium ion (GO:0071276) | 5.45690705 |
| 21 | digestion (GO:0007586) | 5.44714599 |
| 22 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 5.38855249 |
| 23 | lung epithelial cell differentiation (GO:0060487) | 5.29688480 |
| 24 | regulation of necrotic cell death (GO:0010939) | 5.28814484 |
| 25 | lung cell differentiation (GO:0060479) | 5.06420379 |
| 26 | negative regulation of meiotic cell cycle (GO:0051447) | 5.06228037 |
| 27 | histone H2B ubiquitination (GO:0033523) | 4.98993188 |
| 28 | chemokine-mediated signaling pathway (GO:0070098) | 4.98172782 |
| 29 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 4.82425097 |
| 30 | negative regulation of epithelial cell differentiation (GO:0030857) | 4.81603430 |
| 31 | cGMP biosynthetic process (GO:0006182) | 4.69932114 |
| 32 | regulation of epidermal cell differentiation (GO:0045604) | 4.69843709 |
| 33 | neural crest cell migration (GO:0001755) | 4.58575374 |
| 34 | tight junction assembly (GO:0070830) | 4.57030924 |
| 35 | negative regulation of stem cell differentiation (GO:2000737) | 4.27101753 |
| 36 | mitochondrial calcium ion transport (GO:0006851) | 4.19898540 |
| 37 | polyketide metabolic process (GO:0030638) | 4.19652445 |
| 38 | doxorubicin metabolic process (GO:0044598) | 4.19652445 |
| 39 | daunorubicin metabolic process (GO:0044597) | 4.19652445 |
| 40 | retinal metabolic process (GO:0042574) | 4.05755890 |
| 41 | positive regulation of protein homooligomerization (GO:0032464) | 4.01670730 |
| 42 | protein autoprocessing (GO:0016540) | 3.87073360 |
| 43 | positive regulation of prostaglandin secretion (GO:0032308) | 3.74692424 |
| 44 | regulation of Notch signaling pathway (GO:0008593) | 3.71337398 |
| 45 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.69706976 |
| 46 | cellular aldehyde metabolic process (GO:0006081) | 3.63005326 |
| 47 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.56314312 |
| 48 | primary alcohol catabolic process (GO:0034310) | 3.53048133 |
| 49 | natural killer cell mediated immunity (GO:0002228) | 3.52270986 |
| 50 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.52270986 |
| 51 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.45970581 |
| 52 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 3.29181551 |
| 53 | regulation of phospholipase A2 activity (GO:0032429) | 3.21396768 |
| 54 | GDP-mannose metabolic process (GO:0019673) | 3.18230149 |
| 55 | regulation of prostaglandin secretion (GO:0032306) | 3.13676762 |
| 56 | histone H2A ubiquitination (GO:0033522) | 3.07233880 |
| 57 | Golgi transport vesicle coating (GO:0048200) | 3.06914137 |
| 58 | COPI coating of Golgi vesicle (GO:0048205) | 3.06914137 |
| 59 | ethanol oxidation (GO:0006069) | 3.04788233 |
| 60 | regulation of epidermis development (GO:0045682) | 3.03914955 |
| 61 | protein retention in ER lumen (GO:0006621) | 2.96648745 |
| 62 | regulation of epithelial to mesenchymal transition (GO:0010717) | 2.90475992 |
| 63 | cGMP metabolic process (GO:0046068) | 2.89724234 |
| 64 | glycoside metabolic process (GO:0016137) | 2.81577612 |
| 65 | fucose catabolic process (GO:0019317) | 2.81553093 |
| 66 | L-fucose metabolic process (GO:0042354) | 2.81553093 |
| 67 | L-fucose catabolic process (GO:0042355) | 2.81553093 |
| 68 | positive regulation of protein oligomerization (GO:0032461) | 2.81231395 |
| 69 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.78687691 |
| 70 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.76138924 |
| 71 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.72211811 |
| 72 | termination of RNA polymerase I transcription (GO:0006363) | 2.65707590 |
| 73 | cyclooxygenase pathway (GO:0019371) | 2.65514528 |
| 74 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.64385611 |
| 75 | response to arsenic-containing substance (GO:0046685) | 2.62174052 |
| 76 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.58969646 |
| 77 | calcium-mediated signaling (GO:0019722) | 2.58678520 |
| 78 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.57902836 |
| 79 | barbed-end actin filament capping (GO:0051016) | 2.56473450 |
| 80 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.55351648 |
| 81 | succinate metabolic process (GO:0006105) | 2.55315613 |
| 82 | behavioral defense response (GO:0002209) | 2.53961335 |
| 83 | behavioral fear response (GO:0001662) | 2.53961335 |
| 84 | heart looping (GO:0001947) | 2.53199743 |
| 85 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.52972243 |
| 86 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.49798073 |
| 87 | bone development (GO:0060348) | 2.49584615 |
| 88 | negative regulation of hormone metabolic process (GO:0032351) | 2.49199327 |
| 89 | potassium ion export (GO:0071435) | 2.47416887 |
| 90 | secretion by tissue (GO:0032941) | 2.47359935 |
| 91 | positive regulation of DNA repair (GO:0045739) | 2.45355700 |
| 92 | dendritic spine organization (GO:0097061) | 2.42905998 |
| 93 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.42116925 |
| 94 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 19.9150890 |
| 95 | negative regulation of digestive system process (GO:0060457) | 19.6338499 |
| 96 | negative regulation of epidermal cell differentiation (GO:0045605) | 14.7594757 |
| 97 | lung secretory cell differentiation (GO:0061140) | 12.3368852 |
| 98 | heart trabecula formation (GO:0060347) | 11.6239779 |
| 99 | negative regulation of epidermis development (GO:0045683) | 11.5584684 |
| 100 | morphogenesis of an epithelial fold (GO:0060571) | 11.3912702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.82069628 |
| 2 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.69743747 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.29533987 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.54307824 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.52240471 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.47155041 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.33267349 |
| 8 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 3.12769500 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.94070640 |
| 10 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.75903204 |
| 11 | KLF5_25053715_ChIP-Seq_YYC3_Human | 2.74338960 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.73100083 |
| 13 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.58903227 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.35830239 |
| 15 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.34933086 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.31568944 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.23859291 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.19202422 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.16667699 |
| 20 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.08512881 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.05154031 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03073700 |
| 23 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.91587875 |
| 24 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.84661882 |
| 25 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.83488772 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.82495205 |
| 27 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.80631464 |
| 28 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.73634647 |
| 29 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.71084021 |
| 30 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.65004567 |
| 31 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.59998416 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57557545 |
| 33 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.55916022 |
| 34 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.55404807 |
| 35 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.51253361 |
| 36 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.51248829 |
| 37 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.51120234 |
| 38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49271007 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45280533 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44106579 |
| 41 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.41085756 |
| 42 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.40563408 |
| 43 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.40416601 |
| 44 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39095139 |
| 45 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.39018191 |
| 46 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37597737 |
| 47 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37475539 |
| 48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.36875930 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.31995943 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30795823 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29292923 |
| 52 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.29179975 |
| 53 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.27925161 |
| 54 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.27575589 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27277392 |
| 56 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.26928953 |
| 57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26581232 |
| 58 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26274358 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23684380 |
| 60 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.23330878 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23098040 |
| 62 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22560959 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22147125 |
| 64 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.21996751 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21966951 |
| 66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21543557 |
| 67 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.20416556 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19544159 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16313283 |
| 70 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14443373 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11841337 |
| 72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09932248 |
| 73 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.09074191 |
| 74 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08679605 |
| 75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07885843 |
| 76 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.07628655 |
| 77 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 1.05567492 |
| 78 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05082970 |
| 79 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.04775828 |
| 80 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.04068652 |
| 81 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02673735 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02124223 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02124223 |
| 84 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.01710776 |
| 85 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01499356 |
| 86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99801736 |
| 87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99745153 |
| 88 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.98089247 |
| 89 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96028727 |
| 90 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94788335 |
| 91 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.93976735 |
| 92 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93837598 |
| 93 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93837598 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92719198 |
| 95 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90545749 |
| 96 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88824570 |
| 97 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.88519195 |
| 98 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87956543 |
| 99 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85486414 |
| 100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84757599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000462_abnormal_digestive_system | 7.14689515 |
| 2 | MP0001664_abnormal_digestion | 6.45307655 |
| 3 | MP0000490_abnormal_crypts_of | 6.34967511 |
| 4 | MP0008004_abnormal_stomach_pH | 5.43578638 |
| 5 | MP0005381_digestive/alimentary_phenotyp | 5.32185256 |
| 6 | MP0005083_abnormal_biliary_tract | 4.88655853 |
| 7 | MP0005165_increased_susceptibility_to | 4.82304942 |
| 8 | MP0003938_abnormal_ear_development | 4.79514933 |
| 9 | MP0000470_abnormal_stomach_morphology | 4.48993922 |
| 10 | MP0001663_abnormal_digestive_system | 4.24839632 |
| 11 | MP0002089_abnormal_postnatal_growth/wei | 3.58765927 |
| 12 | MP0003119_abnormal_digestive_system | 3.49955754 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.46796136 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.42781344 |
| 15 | MP0010155_abnormal_intestine_physiology | 2.36163619 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 1.99120629 |
| 17 | MP0004036_abnormal_muscle_relaxation | 1.84352647 |
| 18 | MP0002909_abnormal_adrenal_gland | 1.80175718 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.74019395 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 1.65646661 |
| 21 | MP0005666_abnormal_adipose_tissue | 1.59655817 |
| 22 | MP0001873_stomach_inflammation | 1.36229886 |
| 23 | MP0006054_spinal_hemorrhage | 1.31603373 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.29545235 |
| 25 | MP0005409_darkened_coat_color | 1.24514336 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.21703014 |
| 27 | MP0001270_distended_abdomen | 1.18897639 |
| 28 | MP0002233_abnormal_nose_morphology | 1.18811086 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.03058001 |
| 30 | MP0009250_abnormal_appendicular_skeleto | 1.02607586 |
| 31 | MP0000003_abnormal_adipose_tissue | 0.99598581 |
| 32 | MP0000477_abnormal_intestine_morphology | 0.98132693 |
| 33 | MP0000428_abnormal_craniofacial_morphol | 0.96721370 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 0.92774468 |
| 35 | MP0001286_abnormal_eye_development | 0.91867695 |
| 36 | MP0005275_abnormal_skin_tensile | 0.88090673 |
| 37 | MP0000343_altered_response_to | 0.85457164 |
| 38 | MP0005501_abnormal_skin_physiology | 0.80099035 |
| 39 | MP0010630_abnormal_cardiac_muscle | 0.76224643 |
| 40 | MP0005310_abnormal_salivary_gland | 0.76197791 |
| 41 | MP0002735_abnormal_chemical_nociception | 0.71297606 |
| 42 | MP0002163_abnormal_gland_morphology | 0.70686004 |
| 43 | MP0001666_abnormal_nutrient_absorption | 0.70285029 |
| 44 | MP0001346_abnormal_lacrimal_gland | 0.69697902 |
| 45 | MP0003959_abnormal_lean_body | 0.67161304 |
| 46 | MP0005503_abnormal_tendon_morphology | 0.66828083 |
| 47 | MP0002796_impaired_skin_barrier | 0.66648148 |
| 48 | MP0005408_hypopigmentation | 0.66400876 |
| 49 | MP0000566_synostosis | 0.62994904 |
| 50 | MP0000613_abnormal_salivary_gland | 0.60737132 |
| 51 | MP0000681_abnormal_thyroid_gland | 0.58113529 |
| 52 | MP0004858_abnormal_nervous_system | 0.56151846 |
| 53 | MP0001243_abnormal_dermal_layer | 0.55842528 |
| 54 | MP0004484_altered_response_of | 0.54735910 |
| 55 | MP0005375_adipose_tissue_phenotype | 0.54390478 |
| 56 | MP0001188_hyperpigmentation | 0.53274971 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 0.50684287 |
| 58 | MP0000858_altered_metastatic_potential | 0.50644111 |
| 59 | MP0003186_abnormal_redox_activity | 0.43882122 |
| 60 | MP0003448_altered_tumor_morphology | 0.43704346 |
| 61 | MP0002128_abnormal_blood_circulation | 0.43287844 |
| 62 | MP0003283_abnormal_digestive_organ | 0.42838212 |
| 63 | MP0005508_abnormal_skeleton_morphology | 0.42363527 |
| 64 | MP0005365_abnormal_bile_salt | 0.42140822 |
| 65 | MP0001845_abnormal_inflammatory_respons | 0.39225342 |
| 66 | MP0000313_abnormal_cell_death | 0.38574538 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.37746268 |
| 68 | MP0002019_abnormal_tumor_incidence | 0.37112216 |
| 69 | MP0003252_abnormal_bile_duct | 0.36253479 |
| 70 | MP0009764_decreased_sensitivity_to | 0.35488848 |
| 71 | MP0009840_abnormal_foam_cell | 0.35419650 |
| 72 | MP0002249_abnormal_larynx_morphology | 0.34771692 |
| 73 | MP0002098_abnormal_vibrissa_morphology | 0.34520016 |
| 74 | MP0000163_abnormal_cartilage_morphology | 0.34128237 |
| 75 | MP0002419_abnormal_innate_immunity | 0.33389998 |
| 76 | MP0003935_abnormal_craniofacial_develop | 0.32240180 |
| 77 | MP0000367_abnormal_coat/_hair | 0.32092931 |
| 78 | MP0010094_abnormal_chromosome_stability | 0.31922324 |
| 79 | MP0004233_abnormal_muscle_weight | 0.31256372 |
| 80 | MP0005058_abnormal_lysosome_morphology | 0.30968708 |
| 81 | MP0000627_abnormal_mammary_gland | 0.29827221 |
| 82 | MP0002095_abnormal_skin_pigmentation | 0.29226046 |
| 83 | MP0001849_ear_inflammation | 0.29211637 |
| 84 | MP0005164_abnormal_response_to | 0.27587033 |
| 85 | MP0003633_abnormal_nervous_system | 0.27525544 |
| 86 | MP0005023_abnormal_wound_healing | 0.26612667 |
| 87 | MP0001731_abnormal_postnatal_growth | 0.26521674 |
| 88 | MP0002282_abnormal_trachea_morphology | 0.26103012 |
| 89 | MP0008260_abnormal_autophagy | 0.26102047 |
| 90 | MP0003795_abnormal_bone_structure | 0.25928315 |
| 91 | MP0004883_abnormal_blood_vessel | 0.25192450 |
| 92 | MP0008875_abnormal_xenobiotic_pharmacok | 0.24855654 |
| 93 | MP0001697_abnormal_embryo_size | 0.24513866 |
| 94 | MP0005330_cardiomyopathy | 0.24487195 |
| 95 | MP0002084_abnormal_developmental_patter | 0.22431395 |
| 96 | MP0005332_abnormal_amino_acid | 0.21551601 |
| 97 | MP0003984_embryonic_growth_retardation | 0.20933432 |
| 98 | MP0002080_prenatal_lethality | 0.20094509 |
| 99 | MP0002722_abnormal_immune_system | 0.20086341 |
| 100 | MP0003941_abnormal_skin_development | 0.19596867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the lumbar spine (HP:0100712) | 8.37061774 |
| 2 | Mesomelia (HP:0003027) | 8.25580867 |
| 3 | Beaking of vertebral bodies (HP:0004568) | 7.76851970 |
| 4 | Thoracic kyphosis (HP:0002942) | 7.34067632 |
| 5 | Radial bowing (HP:0002986) | 7.18748975 |
| 6 | Redundant skin (HP:0001582) | 6.65927229 |
| 7 | Long toe (HP:0010511) | 6.14048720 |
| 8 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 5.60338711 |
| 9 | Abnormality of the thoracic spine (HP:0100711) | 5.26776338 |
| 10 | Bowed forearm bones (HP:0003956) | 5.09936437 |
| 11 | Bowing of the arm (HP:0006488) | 5.09936437 |
| 12 | Tubulointerstitial nephritis (HP:0001970) | 4.55357775 |
| 13 | Ovoid vertebral bodies (HP:0003300) | 4.55165118 |
| 14 | Abnormal tarsal ossification (HP:0008369) | 4.51050609 |
| 15 | Broad hallux (HP:0010055) | 4.28655758 |
| 16 | Gout (HP:0001997) | 4.14024532 |
| 17 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 4.05614044 |
| 18 | Ventricular fibrillation (HP:0001663) | 3.83395259 |
| 19 | Flared metaphyses (HP:0003015) | 3.76666020 |
| 20 | Exercise-induced myalgia (HP:0003738) | 3.65304369 |
| 21 | Limited elbow extension (HP:0001377) | 3.59815198 |
| 22 | Hypoplasia of the radius (HP:0002984) | 3.57057200 |
| 23 | Abnormality of the epiphyses of the hand (HP:0005924) | 3.54935445 |
| 24 | Broad toe (HP:0001837) | 3.47596287 |
| 25 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 3.38414421 |
| 26 | Amyloidosis (HP:0011034) | 3.17690142 |
| 27 | Abnormal foot bone ossification (HP:0010675) | 3.04986743 |
| 28 | Short metatarsal (HP:0010743) | 2.97257389 |
| 29 | Follicular hyperkeratosis (HP:0007502) | 2.78610266 |
| 30 | Lumbar hyperlordosis (HP:0002938) | 2.70150979 |
| 31 | Aplasia/Hypoplasia of metatarsal bones (HP:0001964) | 2.55673509 |
| 32 | Forearm undergrowth (HP:0009821) | 2.54136862 |
| 33 | Ankle clonus (HP:0011448) | 2.52478022 |
| 34 | Renal salt wasting (HP:0000127) | 2.50647308 |
| 35 | Broad finger (HP:0001500) | 2.40623398 |
| 36 | Tubulointerstitial fibrosis (HP:0005576) | 2.39725573 |
| 37 | Sprengel anomaly (HP:0000912) | 2.31655959 |
| 38 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.30233209 |
| 39 | Abnormality of carpal bone ossification (HP:0006257) | 2.26711755 |
| 40 | Rhabdomyolysis (HP:0003201) | 2.24316919 |
| 41 | Broad phalanx (HP:0006009) | 2.20448254 |
| 42 | Muscle stiffness (HP:0003552) | 2.16022232 |
| 43 | Opisthotonus (HP:0002179) | 2.13368141 |
| 44 | Hepatocellular necrosis (HP:0001404) | 2.10102365 |
| 45 | Pili torti (HP:0003777) | 2.08680903 |
| 46 | Broad long bones (HP:0005622) | 2.06821011 |
| 47 | Arachnodactyly (HP:0001166) | 2.06032959 |
| 48 | Increased purine levels (HP:0004368) | 2.05548654 |
| 49 | Hyperuricemia (HP:0002149) | 2.05548654 |
| 50 | Myoglobinuria (HP:0002913) | 2.01934573 |
| 51 | Tubular atrophy (HP:0000092) | 2.01437986 |
| 52 | Broad metatarsal (HP:0001783) | 11.7417643 |
| 53 | Vertebral arch anomaly (HP:0008438) | 11.6931536 |
| 54 | Short nail (HP:0001799) | 10.7254339 |
| 55 | Hepatic necrosis (HP:0002605) | 1.93970918 |
| 56 | Abdominal situs inversus (HP:0003363) | 1.85528934 |
| 57 | Abnormality of abdominal situs (HP:0011620) | 1.85528934 |
| 58 | Conjugated hyperbilirubinemia (HP:0002908) | 1.83575223 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83101778 |
| 60 | High anterior hairline (HP:0009890) | 1.77476491 |
| 61 | Joint laxity (HP:0001388) | 1.76302625 |
| 62 | Disproportionate tall stature (HP:0001519) | 1.76234068 |
| 63 | Hyperammonemia (HP:0001987) | 1.71989331 |
| 64 | Soft skin (HP:0000977) | 1.68156808 |
| 65 | Ankle contracture (HP:0006466) | 1.67856127 |
| 66 | Abnormal pupillary function (HP:0007686) | 1.67479598 |
| 67 | Abnormal hand bone ossification (HP:0010660) | 1.62722350 |
| 68 | Periodontitis (HP:0000704) | 1.62077421 |
| 69 | Hypotension (HP:0002615) | 1.61563737 |
| 70 | Abnormal ossification of hand bones (HP:0005921) | 1.59913757 |
| 71 | Abnormality of dentin (HP:0010299) | 1.58106054 |
| 72 | Tubulointerstitial abnormality (HP:0001969) | 1.56383548 |
| 73 | Glomerulosclerosis (HP:0000096) | 1.52760280 |
| 74 | Dilated cardiomyopathy (HP:0001644) | 1.52374450 |
| 75 | Increased density of long bones (HP:0006392) | 1.49503249 |
| 76 | Osteopenia (HP:0000938) | 1.48824650 |
| 77 | Abnormality of glycolysis (HP:0004366) | 1.48096607 |
| 78 | Ventricular arrhythmia (HP:0004308) | 1.47917601 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 1.47120361 |
| 80 | Hyperphosphatemia (HP:0002905) | 1.40554223 |
| 81 | Mucopolysacchariduria (HP:0008155) | 1.40357939 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.40357939 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.40178341 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.40178341 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.40178341 |
| 86 | Prominent forehead (HP:0011220) | 1.39100422 |
| 87 | Diaphragmatic weakness (HP:0009113) | 1.38162854 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.38085126 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 1.38085126 |
| 90 | Poor head control (HP:0002421) | 1.37212956 |
| 91 | Syncope (HP:0001279) | 1.36833688 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 1.36250892 |
| 93 | Bulbar palsy (HP:0001283) | 1.33663498 |
| 94 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.29976572 |
| 95 | Intrahepatic cholestasis (HP:0001406) | 1.29058084 |
| 96 | Sparse eyelashes (HP:0000653) | 1.27146959 |
| 97 | Spastic tetraparesis (HP:0001285) | 1.25527948 |
| 98 | Distal upper limb amyotrophy (HP:0007149) | 1.23677914 |
| 99 | Upper limb amyotrophy (HP:0009129) | 1.23677914 |
| 100 | Abnormality of renal excretion (HP:0011036) | 1.22485002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 4.94416109 |
| 2 | ERN1 | 2.43386168 |
| 3 | NEK1 | 15.7840101 |
| 4 | ZAP70 | 1.67289809 |
| 5 | TRIB3 | 1.56012174 |
| 6 | MST1R | 1.55128058 |
| 7 | CDK8 | 1.44926945 |
| 8 | TAOK1 | 1.31607031 |
| 9 | NME1 | 1.20354019 |
| 10 | STK16 | 1.15844700 |
| 11 | IRAK3 | 0.81810017 |
| 12 | EPHA2 | 0.69875344 |
| 13 | EEF2K | 0.66754851 |
| 14 | PKN2 | 0.64609957 |
| 15 | DMPK | 0.63318069 |
| 16 | PIK3CG | 0.62210852 |
| 17 | SCYL2 | 0.61507984 |
| 18 | PDGFRB | 0.59100699 |
| 19 | MST4 | 0.59062073 |
| 20 | RIPK1 | 0.58449050 |
| 21 | STK4 | 0.57517151 |
| 22 | PASK | 0.57497586 |
| 23 | NME2 | 0.56206899 |
| 24 | EPHB2 | 0.51504158 |
| 25 | STK24 | 0.49366217 |
| 26 | ZAK | 0.45810092 |
| 27 | PRKCI | 0.44984004 |
| 28 | MAPKAPK5 | 0.43862462 |
| 29 | MAP3K3 | 0.42576158 |
| 30 | LMTK2 | 0.40513511 |
| 31 | TAOK2 | 0.39256874 |
| 32 | TESK1 | 0.38870653 |
| 33 | BLK | 0.36426004 |
| 34 | PIM2 | 0.34986121 |
| 35 | BMPR2 | 0.34901482 |
| 36 | DDR2 | 0.34359507 |
| 37 | MYLK | 0.34053279 |
| 38 | MET | 0.32737067 |
| 39 | MAP2K6 | 0.32451336 |
| 40 | PTK2 | 0.31759472 |
| 41 | EIF2AK3 | 0.31093392 |
| 42 | IRAK1 | 0.30903976 |
| 43 | IRAK2 | 0.28315710 |
| 44 | MAP3K12 | 0.26696304 |
| 45 | CSK | 0.26419454 |
| 46 | ERBB4 | 0.25787794 |
| 47 | STK39 | 0.24611548 |
| 48 | PRPF4B | 0.21978569 |
| 49 | MAP3K5 | 0.21633048 |
| 50 | MAPK11 | 0.20907650 |
| 51 | ILK | 0.20825937 |
| 52 | MAP2K3 | 0.20822677 |
| 53 | PDK2 | 0.19937682 |
| 54 | CSNK1G3 | 0.19584585 |
| 55 | MAPKAPK3 | 0.19282036 |
| 56 | PRKD2 | 0.19153746 |
| 57 | MAP3K6 | 0.18382696 |
| 58 | MAP3K10 | 0.17574407 |
| 59 | PRKD3 | 0.17524249 |
| 60 | PTK6 | 0.16679674 |
| 61 | CSNK1G1 | 0.16656767 |
| 62 | CCNB1 | 0.15956017 |
| 63 | IRAK4 | 0.14812750 |
| 64 | MARK2 | 0.14739110 |
| 65 | TGFBR1 | 0.14704654 |
| 66 | CSNK1A1L | 0.13557566 |
| 67 | MAP2K7 | 0.12946068 |
| 68 | PAK4 | 0.12509822 |
| 69 | ALK | 0.11993000 |
| 70 | BCKDK | 0.11117725 |
| 71 | CSNK1E | 0.10800043 |
| 72 | PRKCD | 0.09228332 |
| 73 | EGFR | 0.08974397 |
| 74 | ERBB3 | 0.08744701 |
| 75 | MAP3K7 | 0.07988371 |
| 76 | CDK11A | 0.07126661 |
| 77 | CDK15 | 0.06867993 |
| 78 | HIPK2 | 0.06748056 |
| 79 | CDK9 | 0.06739273 |
| 80 | CSNK1G2 | 0.06730689 |
| 81 | TYRO3 | 0.06673459 |
| 82 | ABL2 | 0.06193893 |
| 83 | ADRBK1 | 0.05083459 |
| 84 | CDK18 | 0.04975148 |
| 85 | RPS6KB1 | 0.04675622 |
| 86 | PAK1 | 0.04615414 |
| 87 | OXSR1 | 0.04135311 |
| 88 | RPS6KA2 | 0.02402150 |
| 89 | BUB1 | 0.02226785 |
| 90 | CDK14 | 0.02000179 |
| 91 | RET | 0.00887942 |
| 92 | PRKD1 | 0.00816501 |
| 93 | SRC | 0.00722234 |
| 94 | MELK | 0.00230843 |
| 95 | CDK7 | 0.00201547 |
| 96 | AKT2 | -0.0052357 |
| 97 | PRKCB | -0.0040155 |
| 98 | PRKCZ | -0.0037936 |
| 99 | NEK2 | -0.0021925 |
| 100 | RPS6KB2 | -0.0012604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.72667389 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.29821822 |
| 3 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 3.00625263 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.96686973 |
| 5 | Tight junction_Homo sapiens_hsa04530 | 2.75614351 |
| 6 | Hepatitis C_Homo sapiens_hsa05160 | 2.74874610 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.63846306 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47202517 |
| 9 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.38283199 |
| 10 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.38252962 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.36501149 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.35340109 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.28015492 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.24899794 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19652724 |
| 16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.04789367 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94206248 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91816251 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.90209893 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.88263407 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.66706138 |
| 22 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61524711 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51088508 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.48534195 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.39744173 |
| 26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.26683118 |
| 27 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.25900708 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.25396215 |
| 29 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.24840479 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.24414016 |
| 31 | Mineral absorption_Homo sapiens_hsa04978 | 1.23554916 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21621683 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.21141281 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20229070 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19638346 |
| 36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.14501136 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09726825 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01647875 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01402266 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00816667 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99506663 |
| 42 | Purine metabolism_Homo sapiens_hsa00230 | 0.99182895 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.98740031 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97991261 |
| 45 | Proteasome_Homo sapiens_hsa03050 | 0.97076361 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94003307 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.92532564 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91022348 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89741052 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.88815680 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84863370 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83467574 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80297795 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78303748 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74197494 |
| 56 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72062301 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71710635 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69165709 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67855423 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.67473861 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66585064 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.66579933 |
| 63 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66178655 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.63533980 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61354704 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60971742 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60546776 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59110910 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55930605 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54548425 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53562762 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53422744 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53004163 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49122983 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48645996 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48341720 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.47884370 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46213311 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45886195 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43589718 |
| 81 | Protein export_Homo sapiens_hsa03060 | 0.42343942 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41904442 |
| 83 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41451650 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41421442 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40245862 |
| 86 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36517623 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33212852 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33096070 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31671964 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31608546 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31138472 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30957231 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.29969229 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29641716 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29156750 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27992429 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27877311 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25962669 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.25795205 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.17776207 |

